Table 1.
Clinical characteristics | N | miR-149 expression | |
---|---|---|---|
Low | High | ||
Sex | |||
Male | 88 | 57 | 31 |
Female | 75 | 46 | 29 |
Age (years) | |||
≤60 | 106 | 68 | 38 |
>60 | 57 | 35 | 22 |
Tumor location | |||
Parenchyma | 104 | 68 | 36 |
Ventricle | 59 | 39 | 20 |
Tumor size | |||
≤3 cm | 84 | 52 | 32 |
>3 cm | 79 | 51 | 28 |
WHO grade* | |||
I+II | 80 | 36 | 44 |
III+IV | 83 | 67 | 16 |
Karnofsky score* | |||
≤80 | 94 | 88 | 6 |
>80 | 69 | 15 | 54 |
Resection range | |||
Total resection | 93 | 55 | 38 |
Local resection | 70 | 48 | 22 |
Adjuvant therapy | |||
Chemotherapy only | 100 | 63 | 37 |
Radiotherapy and chemotherapy | 63 | 40 | 23 |
Recurrence time* | |||
≤3 months | 97 | 68 | 29 |
>3 months | 66 | 33 | 33 |
Survival duration* | |||
<15 months | 81 | 71 | 10 |
≥15 months | 82 | 32 | 50 |
P<0.05, performed by χ2 test.